German orthopedic implant maker Syntellix said today that it’s planning an initial public offering on the Singapore Stock Exchange and named a new CFO.
Syntellix makes screws and pins from a magnesium-based material it developed, called Magnezix, that’s designed to be resorbed and converted into bone over time. Its products are approved in Mexico, Vietnam and Indonesia, Syntellix said.
The Hanover-based company said the IPO was unanimously approved at an April 30 shareholders meeting, authorizing the flotation of 1.5 million shares.
“The company had already successfully mastered and fulfilled important regulatory requirements for the respective IPO in Singapore,” according to a press release.
Syntellis also said it named Amir Ghoreishi as CFO and chief scientific officer, saying he will “play a key role in the further preparations for the intended IPO and, as CSO International, he will also help expedite further international expansion.”
